SUVRETTA CAPITAL MANAGEMENT, LLC - THERAPEUTICS ACQUISITION COR ownership

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of THERAPEUTICS ACQUISITION COR
ValueSharesWeighting
Q2 2021$21,017,000
+85.8%
2,045,600
+90.1%
0.31%
+88.0%
Q1 2021$11,309,0001,076,0000.17%
Other shareholders
THERAPEUTICS ACQUISITION COR shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 350,000$3,679,0001.08%
Bain Capital Life Sciences Investors, LLC 1,000,000$10,510,0000.60%
SPHERA FUNDS MANAGEMENT LTD. 720,000$7,567,0000.58%
Boxer Capital, LLC 1,500,000$15,765,0000.54%
Logos Global Management LP 500,000$5,255,0000.51%
Foresite Capital Management IV, LLC 350,000$3,679,0000.44%
BVF INC/IL 772,226$8,116,0000.30%
SILVERARC CAPITAL MANAGEMENT, LLC 40,000$420,0000.23%
Fairmount Funds Management LLC 50,000$526,0000.22%
Perceptive Advisors 1,500,000$15,765,0000.20%
View complete list of THERAPEUTICS ACQUISITION COR shareholders